文献速递传染病防控与疫情报告卫生政策与健康促进

瑞士2018至2024年出现对达托霉素敏感性降低的万古霉素耐药屎肠球菌vanA ST612

Emergence of vancomycin-resistant Enterococcus faecium vanA ST612 with reduced daptomycin susceptibility, Switzerland, 2018 to 2024.
PubMed 文献 · Euro Surveill · 2025-01-01

本文描述2018至2024年瑞士出现万古霉素耐药屎肠球菌(VREfm)vanA ST612克隆并引发全国暴发调查,该克隆携带与达托霉素敏感性降低相关的遗传改变。核心基因组多位点序列分型(cgMLST)显示五个不同大小的VREfm vanA ST612簇分布于不同医疗区域,以德语区为主,提示多次引入医疗系统。其中一个cgMLST簇(n=79例)感染率为12.8%且仍在持续,主要累及与瑞士医疗系统广泛接触或既往有抗生素暴露的患者。

要点

  • 瑞士2018至2024年出现VREfm vanA ST612克隆并引发全国暴发调查。
  • cgMLST显示五个不同大小的VREfm vanA ST612簇,以德语区为主。
  • 一个cgMLST簇(n=79例)感染率12.8%且仍在持续。

核心结论

  • VREfm vanA ST612克隆在瑞士出现并导致全国暴发调查,其广泛地理传播和检出时间变化提示多次引入医疗系统。
  • 无达托霉素暴露患者中检出达托霉素非敏感提示屎肠球菌在外界压力下持续适应。
  • 未来预防工作应强调评估主动监测培养的障碍、制定经济有效的测序方法国家标准化并促进测序结果与流行病学元数据共享。
  • 本报告旨在提高警惕,该序列型可能已在欧洲国家未被发现地传播。

研究设计与样本

  • 国家医院暴发调查中心受委托评估该克隆在瑞士的时空分布并评价其临床影响。
  • 采用核心基因组多位点序列分型(cgMLST)对VREfm vanA ST612分离株进行分型分析。

主要发现

  • cgMLST揭示五个不同大小的VREfm vanA ST612簇分布于不同医疗区域,但以德语区为主。
  • 其中一个cgMLST簇(n=79例)感染率为12.8%且仍在持续,主要累及与瑞士医疗系统广泛接触或既往有抗生素暴露的患者。
  • 在无既往达托霉素暴露的患者中检出达托霉素非敏感。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We describe the emergence of vancomycin-resistant Enterococcus faecium (VREfm) vanA ST612 in Switzerland from 2018 to 2024 that resulted in a national outbreak investigation. This clone has predisposing genetic alterations associated with reduced daptomycin susceptibility. The National Nosocomial Outbreak Investigation Center was commissioned to assess the temporospatial distribution of this clone in Switzerland and evaluate its clinical impact. Core genome multi-locus sequence typing (cgMLST) revealed five separate VREfm vanA ST612 clusters of different sizes across different healthcare regions, but predominantly in the German-speaking part. The broad geographic dissemination and temporal variation in detection suggests multiple introductions to the healthcare system. One of these cgMLST clusters (n = 79 cases) with an infection rate of 12.8% was ongoing, mainly affecting patients with extensive contact to the Swiss healthcare system or prior antibiotic exposure. The detection of daptomycin non-susceptibility in patients without prior daptomycin exposure suggests ongoing E. faecium adaptation due to external pressures. Future prevention efforts should emphasise assessing barriers for active surveillance cultures, developing a national standard for cost-effective sequencing methods and promoting the sharing of sequencing results together with epidemiological metadata. Our report intends to raise awareness as this sequence type might already be spreading undetected in European countries.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Vuichard-Gysin D, Büchler AC, Blanc DS, et al. Emergence of vancomycin-resistant Enterococcus faecium vanA ST612 with reduced daptomycin susceptibility, Switzerland, 2018 to 2024. Euro Surveill. 2025. PMID: 41234193. doi:10.2807/1560-7917.ES.2025.30.45.2500227

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。